Skip to content

French Renal Epidemiology and Information Network (REIN) Registry

French Renal Epidemiology and Information Network (REIN) Registry in Lorraine

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03967808
Acronym
REIN-LOR
Enrollment
6000
Registered
2019-05-30
Start date
2001-01-31
Completion date
2050-12-31
Last updated
2021-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage Renal Disease

Keywords

Registry, Renal replacement therapy

Brief summary

The Renal Epidemiology and Information Network (REIN) Registry was created in 2002 (after study pilot in 2001) to contribute to the development and evaluation of health strategies aiming at improving prevention and management of end-stage renal disease, and promoting clinical and epidemiological research in this field. It relies on a network of nephrologists, epidemiologists, patients and public health representatives, coordinated regionally and nationally.

Detailed description

The REIN registry is intended to include all end stage renal disease patients on renal replacement therapy (RRT) - either dialysis or transplantation - living in Lorraine area. New (incident) patients are reported from the first day of RRT. Patients with a diagnosis of acute renal failure are excluded, i.e. those who recover all or some renal function within 45 days or are considered as such by experts when they die before 45 days. Patients with pre-emptive grafts and those living with a functioning graft are identified from the transplant database. A set of basic items, including fixed and annually updateable items, was defined for all dialysis patients. Five types of events are reported to the registry on occurrence from the first day of any treatment: (1) renal transplantation, (2) changes in dialysis setting, (3) changes in type of dialysis, (4) transient recovery of renal function and (5) death. The participation rate of centres in Lorraine is 100%. A clinical research assistant visits every dialysis centre to verify the completeness of patient and event registration, by comparing reports to the registry with centre administration files. The REIN guide defines all items to be recorded, includes coding instructions, and serves as a standard for all participating regions. REIN consists of a partnership network and professionals whose Biomedicine Agency is the institutional support. The National level consists of a national coordination, a steering group and a scientific board. Regional level includes a Regional Steering Group led by nephrologist and epidemiological coordinators and an epidemiological unit.

Interventions

None listed

Sponsors

Agence de La Biomédecine
CollaboratorOTHER_GOV
Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients with end stage renal disease on renal replacement therapy

Exclusion criteria

* Patients with acute renal failure ( i.e. those who recover all or some renal function within 45 days or are considered as such by experts when they die before 45 days) * Patient's refusal

Design outcomes

Primary

MeasureTime frameDescription
Occurence of end stage renal disease in Renal Replacement therapyOne yearNew (incident) patients are reported from the first day of Renal Replacement Therapy - either dialysis or renal transplantation

Countries

France

Contacts

Backup ContactFrancis Guillemin, MD,PhD
francis.guillemin@chru-nancy.fr
Primary ContactCarole Ayav, MD
c.ayav@chru-nancy.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026